医学
低密度脂蛋白胆固醇
胆固醇
内科学
PCSK9
羟甲基戊二酰辅酶A还原酶抑制剂
脂蛋白
临床试验
低密度脂蛋白受体
作者
Kausik K. Ray,R. Scott Wright,David Kallend,Wolfgang Köenig,Lawrence A. Leiter,Frederick J. Raal,Jenna A. Bisch,Tara Richardson,Mark Jaros,Peter Wijngaard,John J.P. Kastelein
标识
DOI:10.1056/nejmoa1912387
摘要
Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin–kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) cholesterol levels with infrequent dosing.
科研通智能强力驱动
Strongly Powered by AbleSci AI